Csk phosphorylates Src family protein tyrosine kinases on a tyrosine residue near their C-terminus and downregulates their activity. We previously observed that this regulation requires a stoichiometric ratio of Csk : Src in a time-independent manner. In this report we examined this unusual kinetic behavior and found it to be caused by Src autophosphorylation. First, pre-incubation of Src with ATP-Mg led to time-dependent autophosphorylation of Src, activation of its kinase activity and loss of its ability to be inactivated by Csk. However, the autophosphorylated Src can still be phosphorylated by Csk. The SH2 binding site for phospho-Tyr of this hyperactive and doubly phosphorylated form of Src is not accessible. Second, dephosphorylation of autophosphorylated Src by protein tyrosine phosphatase 1B allowed Src to be inactivated by Csk. Third, protein tyrosine phosphatase 1B preferentially dephosphorylates the Src autophosphorylation site and allows for Src regulation by Csk. Finally, Yes, another member of the Src family, was also only partially inactivated when a sub-stoichiometric amount of Csk was used. Mutation of the tyrosine autophosphorylation site of Yes to a phenylalanine resulted in a mutant Yes enzyme that can be fully inactivated by a sub-stoichiometric amount of Csk in a time-dependent manner. These results demonstrate that Csk phosphorylation inactivates Src and Yes only when they are not previously autophosphorylated and Src autophosphorylation can block the inactivation by Csk phosphorylation. This conclusion suggests a dynamic model for the regulation of the Src family protein tyrosine kinases, which is discussed in the context of previously reported observations on the regulation of Src family protein tyrosine kinases.
Introduction
Protein tyrosine kinases (PTKs) of the Src family play important roles in cellular signal transduction (Brickell, 1992) . There are nine members: Src, Yes, Fyn, Yrk, Fgr, Hck, Lyn, Lck and Blk. Src, Yes and Fyn are expressed ubiquitously, while the other six are expressed in restricted cell types, particularly in haematopoietic cells. These PTKs are key switches in regulating many cellular signal transduction pathways (Thomas and Brugge, 1997) . Most of these enzymes are proto-oncogenes, since their activation by mutation leads to transformation of the host cells (Courtneidge, 1994) . Elevation of the enzymatic activity of some members has been associated with many types of human cancer (Levitzki, 1996) . In tumor cells where Src activity is elevated, the increase in its activity is mostly the result of increased speci®c activity (Bolen et al., 1987; Talamonti et al., 1993) . Furthermore, no mutation has been identi®ed in humans that is responsible for the increased speci®c activity. These ®ndings suggest that elevation of Src activity in human tumor cells is due to a disruption of its regulation. For this reason, understanding the regulation of Src family PTKs may be one of the keys in understanding and designing eective treatment for cancers that have elevated activity of Src family PTKs.
A variety of stimuli, such as various growth factors, UV radiation and oxidative stress can directly or indirectly modulate Src activity. The ability to respond to these signals depends on a complex multi-domain structure. All PTKs in the Src family have an Nterminal acylation motif that is required for their membrane association, a unique region that is heterologous in the family, two Src homology domains (SH3 and SH2) that mediate protein-protein interactions, an SH1 catalytic domain which carries out the phosphorylation reaction, and a regulatory Tyr (Y r ) phosphorylation motif located at the C-terminal region. Another ubiquitous feature among Src family PTKs is the presence of a Tyr autophosphorylation site (Y a ) within the activation loop located in the catalytic domain (Smith et al., 1993) . At the molecular level, several mechanisms that modulate Src activity have been discovered, including binding to other proteins through the SH2 and SH3 domains, phosphorylation of multiple Ser/Thr residues, Tyr phosphorylation by receptor PTKs, autophosphorylation and Csk phosphorylation (Brown and Cooper, 1996) . The major regulatory mechanism is apparently phosphorylation of Y r by Csk, which results in inactivation of Src (Cooper et al., 1986) . In csk knockout mice, Src is mostly unphosphorylated on the C-terminal regulatory Tyr and has elevated kinase activity (Imamoto and Soriano, 1993; Nada et al., 1993) . Src expressed in yeast is minimally phosphorylated on Y r and highly active, while co-expression of Csk led to phosphorylation of Y r and inactivation of Src (Superti-Furga et al., 1993) . These ®ndings establish Csk as the negative regulator of Src family PTKs.
In this communication, we examined the kinetics of Src inactivation by Csk and found that autophosphorylation of Src and Yes blocks their inactivation but not phosphorylation by Csk. This ®nding indicates that autophosphorylation plays a greater role in regulating Src and Yes activity than previously understood and suggests that an altered level of autophosphorylation may be the reason for the paradoxically activated Src in malignant human cell lines with high levels of active Csk.
Results
In order to better understand the regulation of Src by Csk and identify factors that may aect this regulation, we reconstituted this system in vitro with puri®ed recombinant enzymes. In the process, we observed that the inactivation of Src by Csk does not follow a normal enzymatically catalyzed process. Such observations are demonstrated by pre-incubating Src with ATP and dierent amounts of Csk in the presence or absence of MgCl 2 for 30 min before the Src activity was assayed with carboxymethylated-maleylated, reduced lysozyme (RCM-L) (Figure 1a) . In both treatments, Src activity decreased with the increase in the amount of Csk added to the assay. While these results con®rmed that Csk was able to inactivate Src, two points in these results were unexpected. First, it required a stoichiometric amount of Csk to achieve maximal inactivation of Src. Second, prior phosphorylation by Csk (pre-incubation with Csk and ATP-Mg) does not lead to signi®cantly higher levels of inactivation of Src than without prior phosphorylation by Csk (incubation with no MgCl 2 ). This apparent time independence is further demonstrated in Figure 1b . At the selected Csk to Src ratios of 1 : 5 and 1 : 2, approximately 30% and 60% of Src was inactivated and this was independent of the pre-incubation time. Incubation of Src with ATP-MG in the absence of Csk (Csk to Src ratio of 0 : 1) resulted in activation of Src as a result of its autophosphorylation. These observations were not a function of the particular enzyme samples used or methods of their expression and isolation. Data consistent with these observations have been reported repeatedly in the literature with dierent members of the Src family (Okada and Nakagawa, 1989; Ruzzene et al., 1994; Koegl et al., 1994) and Csk from dierent sources. Such consistency suggested that these observations are a re¯ection of the intrinsic properties of Src regulation by Csk phosphorylation.
These observations suggested that Src inactivation by Csk phosphorylation is not a simple ATP-Mgdependent enzymatic conversion of active to inactive Src. There appears to be other factor(s) aecting this process. There are three possibilities that are consistent with these observations: (1) Csk inactivation of Src requires the formation of a stable Src-Csk complex after phosphorylation; (2) Csk is quickly inactivated by incubation with Src and/or ATP-Mg and thus unable to inactivate additional molecules of Src; and (3) Src is quickly transformed upon incubation with Csk and/or ATP-Mg into a form that can not be inactivated by Csk. The ®rst possibility would be consistent with the high stoichiometry of Csk required and the lack of time-dependent inactivation of Src. Furthermore, it was reported that Csk can form a complex with members of the Src family (Ruzzene et al., 1994; Bougeret et al., 1996) . However, evidence from the literature and our own results eliminated this possibility. First, attempts by others (Sabe et al., 1992) and us (data not shown) have failed to detect strong and stable complexes between Csk and Src. Second, Src isolated after pre-incubation with Csk and ATP-Mg remain inactivated (Stover et al., 1994) . Third, the ability of Csk deletion mutants (deletions in SH2 or SH3 domains) to inactivate Src correlates with the kinase activity of the mutants (data not shown). These results indicate that Src inactivation by Csk is a phosphorylation dependent process and does not require the formation of a stable Csk-Src complex. We also examined and eliminated the possibility of Csk being inactivated by incubation with Src and/or ATPMg. Csk undergoes autophosphorylation to a low extent (Amrein et al., 1995) and this does not signi®cantly aect its activity (Oetken et al., 1994; Sun et al., 1997) . Furthermore, Csk is neither phosphorylated nor inactivated by Src even when a near stoichiometric amount of Src was used (Sun et al., 1997) . The elimination of the ®rst two possibilities leaves the third one as the only plausible explanation and we further examined this possibility. PTKs of the Src family undergo autophosphorylation and are activated by this autophosphorylation (Smith et al., 1993). Consistent with this possibility is the recent suggestion that autophosphorylation could activate Src that was inactivated by Csk phosphorylation (Xu et al., 1997; Sicheri et al., 1997) .
To examine the eect of Src autophosphorylation on inactivation by Csk, we examined the correlation between the time courses of Src autophosphorylation and the ability of Src to be inactivated by Csk ( Figure  2 ). In this experiment, Src was incubated with [g-32 P]ATP and MgCl 2 for dierent times and then the proteins were separated by SDS ± PAGE. The phosphorylated proteins were visualized by autoradiography. Src autophosphorylation increased with incubation time and reached over 0.8 mol phosphate/ mol of Src within 1 h. Concomitant with the increase in Src autophosphorylation, the ability of Src to be inactivated by Csk decreased from 80% to about 20%. Longer incubation resulted in complete autophosphorylation and total loss of inactivation by Csk. Preincubation of Src with ATP or MgCl 2 alone did not result in any autophosphorylation and had no eect on its inactivation by Csk. The correlation between Src autophosphorylation and lack of Csk inactivation strongly suggests that autophosphorylation leads to a conformation of Src that cannot be inactivated by Csk phosphorylation.
To further verify this hypothesis, we tested if dephosphorylation of the autophosphorylation site could reverse the eect of autophosphorylation. Protein tyrosine phosphatase (PTP) 1B is a soluble enzyme located in the cytoplasm and has a broad substrate speci®city (Tonks et al., 1988a,b) . We examined whether it could dephosphorylate autophosphorylated Src. Src that was 32 P-labeled by autophosphorylation was incubated with recombinant PTP 1B and EDTA (to inhibit further autophosphorylation by Src) and the level of 32 P-label remaining within Src after the phosphatase treatment was detected by SDS ± PAGE, autoradiography and quanti®ed by liquid scintillation counting (Figure 3 ). Incubation with PTP 1B led to a time dependent loss of phosphate from Src, with approximately 80% of the label being removed within 20 min. We next investigated the eect of PTP 1B dephosphorylation on the ability of Src to be inactivated by Csk. As shown in Table 1 , approximately 10% of autophosphorylated Src is inactivated by Csk (control). After treatment with PTP 1B to dephosphorylate the autophosphorylation site, over 50% the Src activity could be inactivated by Csk. When 1 mM ammonium molybdate (a potent PTP 1B inhibitor that does not aect the Csk or Src kinase activity, data not shown) is included in the PTP 1B treatment to prevent Src dephosphorylation, the majority of Src remained in a state that could not be inactivated by Csk. This result further demonstrated that the ability of Src to be inactivated by Csk is inversely correlated with the level of Src autophosphorylation. Figure 2 was incubated with GST-PTP 1B (50 ng) in the presence of 10 mM Na 2 EDTA for dierent times and the proteins in the reactions were separated by SDS ± PAGE. The phosphorylation level of Src was visualized by autoradiography and quantitated by scintillation counting of the excised Src protein band. The phosphorylation level was normalized to the initial level The above conclusion predicts that if the autophosphorylation of Src is kept at a minimal level, it would be inactivated by a sub-stoichiometric amount of Csk. As demonstrated in Figure 3 , PTP 1B readily dephosphorylates the autophosphorylation site of Src, but it was reported not to dephosphorylate the phosphorylated Y r (Somani et al., 1997) . We took advantage of this apparent speci®city of PTP 1B to examine how the presence of PTP 1B would change Csk inactivation of Src when a sub-stoichiometric amount of Csk was used (Figure 4 ). For this study, a Csk : Src ratio of 1 : 10 was used. Src was pre-incubated in buer alone, or in the presence of ATP-Mg, ATP-Mg+Csk, ATPMg+Csk+PTP 1B or ATP-Mg+PTP 1B for 1 h before Src activity was assayed with RCM-L as the substrate. Prior to determining the activity of Src, ammonium molybdate (1 mM) was added to inhibit the activity of PTP 1B. Incubation with buer alone did not change the Src activity. Incubation with ATP-Mg led to an increase in Src activity of approximately 60% as the result of autophosphorylation. When both ATPMg and Csk were included in the pre-incubation, Src activity did not change signi®cantly compared to the control. This is consistent with minimal inactivation of Src activity observed when a sub-stoichiometric amount of Csk is used as described earlier (Figure 1 ). Pre-incubation with ATP-Mg, Csk and PTP 1B led to a decrease in Src activity of 80% of the initial. The presence of ATP-Mg+PTP 1B in the pre-incubation did not change the Src activity signi®cantly, indicating an equilibrium between autophosphorylation with activation and dephosphorylation by PTP 1B (compare lane 2 vs 5). These results suggests that PTP 1B reverses Src autophosphorylation and that PTP 1B does not directly aect Src activity other than reversing its autophosphorylation. PTP 1B does not aect Csk activity (data not shown). Together these results indicate that by reversing Src autophosphorylation, PTP 1B enables Src to be inactivated by a substoichiometric amount of Csk.
At this point, it was not clear if autophosphorylation blocks phosphorylation by Csk or allows phosphorylation by Csk but blocks the inactivation of Src. To address this issue, we performed peptide mapping of Src after various treatments ( Figure 5 ). In treatment a, incubation with Csk and ATP-Mg led to a loss of 80% of Src activity and an incorporation of approximately 0.8 mol of phosphate per mol of Src. Peptide mapping indicates that phosphate label is speci®cally on Y r in the 4 kD peptide fragment. Incubation of this Csk-inactivated Src in treatment a with PTP 1B (treatment b) led to a partial recovery of the initial Src activity and a loss of about 50% of the phosphate, indicating that PTP 1B could dephosphorylate the Csk phosphorylation site. Incubation of Src with ATP-Mg (treatment c) led to an activation of Src activity of about 60% and an incorporation of 71 ), 12 mM MgCl 2 , 75 mM EPPS-NaOH (pH 8.0), 5% glycerol, 0.005% Triton X-100, 0.05% 2-mercaptoethanol) at 308C for 30 min. For treatment b and d, Src pre-treated as in a and c were incubated with 50 ng PTP 1B and 10 mM EDTA for 15 min, respectively. For treatment e, Src sample pre-treated as in c was further incubated with Csk (0.6 mg) for 30 min. For treatment f, Src sample from treatment e was incubated with PTP 1B and EDTA for 15 min. 10% of the sample from each treatment was withdrawn to determine Src kinase activity, and the rest was fractionated by SDS ± PAGE. The phosphorylation level of Src was determined by Cenrenkov scintillation counting of the excised Src protein bands, which were then used for peptide mapping Figure 4 Inactivation of Src by a sub-stoichiometric amount of Csk in the presence of protein tyrosine phosphatase 1B. Src (0.12 mg per reaction) was incubated with dierent combinations of the following: Csk (12 ng per reaction), ATP (0.1 mM), MgCl 2 (10 mM) and PTP 1B (50 ng) in the kinase assay buer for 30 min before the Src activity was assayed. In the Src activity assay, 1 mM ammonium molybdate was included in all assays to inhibit PTP 1B that is present in some treatments. We have independently veri®ed that ammonium molybdate at this concentration completely inhibits PTP 1B but does not inhibit the activity of Src Since the doubly phosphorylated form is hyperactive, similar to the Y a -phosphorylated form, an important question is if the phospho-Y r is bound to the SH2 domain in this form. This question can be directly addressed by resolution of the tertiary structure of this form. We indirectly addressed this question by asking if the SH2 domain in this form is available to bind phospho-Tyr-Agarose. Phospho-TyrAgarose has been used for the anity puri®cation of a number of SH2 containing proteins (Koegl et al., 1994) . Src was labeled with 32 P-phosphate on Y a , Y r or both and phospho-Tyr Agarose adsorption was performed on all three forms ( Figure 6 ). For Src that was phosphorylated on Y a (stoichiometry of phosphorylation =0.95 mol phosphate per mole of Src), approximately 80% was precipitated by phospho-TyrAgarose (lane 2 vs 1), while for Src phosphorylated on Y r (stoichiometry of phosphorylation =0.99 mol phosphate per mole of Src), only 13% was precipitated (lane 4 vs 3). This result shows that the SH2 domain is accessible for phospho-Tyr-Agarose binding in the phospho-Y a form but not in the phospho-Y r form. For the form that was phosphorylated on both Y a and Y r (stoichiometry of phosphorylation =2.2 mol phosphate per mole of Src), approximately 6% was precipitated by phospho-Try-Agarose, indicating that the SH2 domain binding site for phospho-Tyr is not accessible for phospho-Tyr-Agarose in the doubly phosphorylated form. This conclusion is consistent with the observation that phospho-Y a is preferably dephosphorylated by PTP 1B over phospho-Yr in the doubly phosphorylated form. These two observations together suggests that phospho-Y r is bound to SH2 domain in the doubly phosphorylated form.
Based on the data presented above, it is clear that autophosphorylation of Src blocks its regulation by Csk phosphorylation. To further test this model and investigate whether this applies to other members of the Src family of PTKs, we compared the in vitro inactivation of wild-type and a Phe autophosphorylation mutant of human Yes. Yes is a Src family PTK that is closest to Src in primary structure. We have previously expressed human Yes in a bacterial expression system and shown that this enzyme can be activated by Csk phosphorylation when a stoichiometric amount of Csk was used (Sun and Budde, 1997b) . We generated a mutant Yes enzyme in which the autophosphorylation site, Tyr-426 (Y a ), was changed to a phenylalanine (F a ). To ensure that the mutation does not change the property of the enzyme globally, we compared the thermal stability pro®les of the wild-type, Yes
Ya and the mutant, Yes Fa , enzymes (Figure 7a ). Both enzymes are stable when incubated for 10 min under 258C and start to denature when incubated at above 258C. A 10 min incubation inactivated both enzymes by 50% at 348C and 100% at 418C. The identical thermal inactivation pro®les of the two enzymes indicate that the Y a to F a mutation does not aect the overall structure of the enzyme. We then examined the time course of inactivation of Yes (lanes 1 and 2) , Y r (lanes 3 and 4) or both Y a and Y r (lanes 5 and 6) were prepared as in Figure 5 (treatments a, c and e). One ®fth of each sample was directly applied to SDS ± PAGE (lanes 1, 3 and 5, respectively). The rest was mixed with equal volume of phospho-Tyr-Agarose suspension in the reaction buer and incubated on ice for 10 min. The beads were then pelleted by centrifugation at 4000 r.p.m. for 1 min, and the proteins associated with the beads were analysed by SDS ± PAGE (lanes 2, 4 and 6). The sample applied to all lanes was equivalent to one ®fth of the original sample (3.5 pmol). The 32 P-labeling on Src was determined by liquid scintillation counting of the excised Src band expressed Yes enzyme due to its lower V max than that of Src, which was expressed in a eukaryotic system. In contrast to the inactivation pattern of Yes Ya , Yes
Fa was inactivated virtually completely in a time dependent manner in 40 min. This result further demonstrates that the lack of time-dependent complete inactivation of Yes Ya by Csk is the result of autophosphorylation. Furthermore, these results indicate that the autophosphorylation that blocks Csk inactivation is on the main autophosphorylation site within the activation loop of Yes and Src, although other sites have been reported to also undergo autophosphorylation in the Src family (Osusky et al., 1995; Barker et al., 1995; Jullien et al., 1994) . This result also indicates that autophosphorylation will likely have the same function in modulating Csk regulation of other PTKs in the Src family.
Discussion
Many lines of evidence support the model that Csk phosphorylates the Src family PTKs and down regulates their activity. However attempts to reconstitute the reaction have not been fully successful. It was reported by several independent laboratories (Okada and Nakagawa, 1989; Ruzzene et al., 1994; Koegl et al., 1994; Xu et al., 1997 ) that a Csk : Src molar ratio of more than one was required to achieve a reasonable level of Src inactivation. In the present study we found that this apparent ineciency is the result of Src autophosphorylation. We demonstrated that after Src is autophosphorylated, it can be phosphorylated but not inactivated by Csk. When autophosphorylation is kept to a minimum or prevented by inclusion of a Y a -speci®c PTP or mutating the Y a to phenylalanine, Src and Yes can be eectively inactivated by a sub-stoichiometric amount of Csk in a time-dependent manner. These ®ndings indicate that autophosphorylation not only directly activates Src, but is also a key element in its regulation by Csk phosphorylation. These results provide a better understanding of how Src activity is controlled by its phosphorylation state on Y a and Y r .
A comprehensive model based on the ®ndings in this report and consistent with observations in the literature is shown in Figure 8 . In this model, the phosphorylation of only Y a and Y r is considered. Once autophosphorylated on Y a , Src becomes hyperactive regardless of the phosphorylation status of Y r , although Y r can still be phosphorylated to form the doubly phosphorylated form. In support of this model, Lck that is phosphorylated on both Y a and Y r and hyperactive was recently isolated from Jurkat human leukemic T cells (Hardwick and Sefton, 1997) . Csk phosphorylation can only inactivate Src that is not autophosphorylated. Two dierent protein tyrosine phosphatases are responsible for the dephosphorylation of the two phosphorylation sites, respectively. The conversion of the inactive Y r -phosphorylated form to the hyperactive doubly phosphorylated form by autophosphorylation (a trans-mechanism) has not been observed by us. The two hyperactive forms may be especially relevant to understanding the oncogenic potential of Src in tumorigenesis. Fa . The enzymes in kinase assay buer were incubated at dierent temperatures for 10 min, cooled on ice and the activities were assayed with polyE 4 Y as the substrate. The assays were carried out as described (Sun and Budde, 1997b) . (b) Inactivation of wild-type and mutant Yes by Csk phosphorylation. Yes enzymes (2 mg per reaction) were incubated with Csk (0.1 mg per reaction), ATP (0.1 mM) and MgCl 2 (10 mM) for dierent time and then the activity of Yes was assayed with RCM-lysozyme as the substrate Figure 8 Regulation of Src activity by reversible autophosphorylation and Csk phosphorylation. The autophosphorylation site is indicated as Y a and Csk phosphorylation site is indicated as Y r . PTP x is the protein tyrosine phosphatase that speci®cally dephosphorylate Y r The conclusion in this paper is consistent with our current knowledge of how Src is inactivated by Y r phosphorylation, and further expands the current model. A comparison of crystal structures of Src inactivated by Y r phosphorylation (Xu et al., 1997) , with other activated PTKs, including Lck (Yamaguchi and Hendrickson, 1996) and insulin receptor kinase (Hubbard, 1997) suggests that the inactivation caused by Y r -phosphorylation of Src is executed by the disposition of Helix C located in the ATP-binding lobe of the catalytic domain. Helix C contains the conserved Glu-310, which is essential for the activity of kinases. In the active kinases, the side chain of this residue projects into the catalytic cleft and forms a salt bridge with Lys-295, a residue important for binding ATP. In the structure of the inactive Src, however, Helix C moves away from the catalytic cleft and Glu-310 faces outward where it is stabilized by a salt-bridge with Arg-385. Two groups of interactions are responsible for the disposition of Helix C: the SH2-phospho-Y r binding dependent interactions of the Cend of Helix C with the linker between the SH2 and SH1 catalytic domain, and the interaction between the N-end of Helix C to the beginning segment of the activation loop. It has been proposed that removal of either one of these two interactions would result in rearrangement of Helix C and activation of Src. It is expected that phosphorylation of Y a would change the conformation of the activation loop and remove the constraints on Helix C from the N-end. Our results veri®ed this hypothesis and demonstrated that phosphorylation of Y a does lead to activation of Src even when Y r is also phosphorylated.
The results raise the question what happens to the interaction between SH2 and the phospho-Y r in the doubly phosphorylated and hyper-activated Src? Two experiments in this current study addressed this question. First, the phospho-Y r in doubly phosphorylated Src appears not accessible for dephosphorylation by PTP 1B. Second, the SH2 domain in the doubly phosphorylated Src is not available to bind to phospho-Tyr-Agarose. These two observations together suggest that phospho-Y r is still bound to the SH2 domain in the doubly phosphorylated form. Although our results demonstrated that this form of Src is hyperactive, similar to autophosphorylated Src, these two forms are expected to have dierent properties, such as their ability to interact with phospho-Tyr containing proteins.
Besides proposing a far more important role for autophosphorylation in controlling Src activity, this model also positions the PTP that speci®cally dephosphorylates the Src autophosphorylation site at a critical point in the regulation of Src activity and function. The importance of this enzyme is demonstrated by two experiments in this study. First, in the absence of such a PTP activity, inactivation of Src requires a stoichiometric amount of Csk. In the presence of PTP 1B activity, Src can be eectively inactivated by a sub-stoichiometric amount of Csk. Second, Src that is phosphorylated on both Y a and Y r are hyperactive, and dephosphorylation of Y a by this phosphatase converts Src to the inactive form that is only phosphorylated on Y r . Our data presented in this study indicate that PTP 1B is able to serve this function in that it selectively dephosphorylates Y a . The preference of PTP 1B for phospho-Y a is likely the result of phospho-Y r being bound to the SH2 domain and thus not accessible to PTP 1B. Further study is required to verify this role in vivo and understand the basis for the preference for PTP 1B. Several PTPs have been proposed to speci®cally dephosphorylate the Y r of Src, including SH2 domain-containing PTP (Somani et al., 1997) and trans-membrane PTP a (Zheng et al., 1992) and PTP l (Chappel et al., 1997) .
Consistent with this model is the observation that in normal untransformed cells, Src is fully phosphorylated on Y r but not on Y a . Activation of Src during mitosis is accompanied by the dephosphorylation of Y r (Bagrodia et al., 1991) . However, Src activation and transforming potential correlate directly to the autophosphorylation status, not to the phosphorylation level of Y r (Jove et al., 1989; Iba et al., 1985; Cheng et al., 1988) . These pieces of evidence support our conclusion that autophosphorylation of Src family PTKs overrides their regulation by Csk phosphorylation.
This model also provides a more plausible explanation for several observations that have been reported in the literature. First, the autophosphorylation mutant of Src (Tyr to Phe) has much reduced transforming potential than the wild type enzyme although this mutation does not greatly aect the activity of the enzyme (Kmiecik and Shalloway, 1987) . Our current model would propose that the major dierence in the wild-type and the mutant enzymes is not the enzymatic activity but the ability of the wild-type Src to autophosphorylate and escape Csk inactivation, while the mutant enzyme, incapable of autophosphorylation, will be inactivated by Csk and thus have reduced transforming potential. Second, in colorectal cancer cell lines with activated Src, Csk is highly expressed and fully active (Li et al., 1996) and furthermore the level of Csk expression corresponds to the elevated levels of Src and Yes activities (Watanabe et al., 1995) . These ®ndings led to the suggestion that Csk may not have an anti-oncogenic role to play through the negative regulation of Src family kinases in colorectal carcinogenesis. It was recently reported (Chedin et al., 1997) that human breast tumor tissues contain two major soluble and highly active PTKs, one is Src and the other is Csk. Relative to these observations in both the colorectal and breast cancer tissue and cell lines, our model would suggest that Src and Yes are autophosphorylated and thus are able to escape the inactivation by Csk phosphorylation. A direct examination of Src activity, phosphorylation level on Y a and Y r , Csk protein level and kinase activity in tumor tissues and cell lines will further test this model.
Materials and methods

Enzymes and other chemicals
Recombinant Src (3900 U mg 71 with polyE 4 Y as substrate) was expressed in and puri®ed from baculovirus-infected insect cells (Budde et al., 1993 32 P]RCM-lysozyme as substrate) were expressed as a glutathione S-transferase (GST) fusion protein in Escherichia coli and puri®ed as described (Sun and Budde, 1995) . The Csk used in this study was tagged with the 10-amino acid strep-tag at the C-terminus and puri®ed to apparent homogeneity. The E. coli expressed Csk has a speci®c activity similar to that puri®ed from the brain. The PTP 1B was in the form of a full length GST-PTP 1B fusion protein. GST-PTP 1B phosphatase activity is readily lost through one freeze-thaw cycle but stable for at least 6 months when stored in 50% glycerol at 7208C. One unit of PTP 1B activity is de®ned as the amount of enzyme that catalyzes the release of 1 nmole of phosphate per min from [
32 P]RCM-L. PhosphoTyr-Agarose was purchased from Sigma Chemical Co.
Protein tyrosine kinase and protein tyrosine phosphatase activity assays Routine PTK activity assays were carried out as described previously (Sun and Budde, 1997a) . The PTP activity was determined by measuring the ability to dephosphorylate [ 32 P]RCM-L, that was phosphorylated by Src as described (Tonks et al., 1991) . The assay was conducted in a 50 ml volume that included 50 mM Tris-Cl (pH 7.5), 0.05% bmercaptoethanol, 0.1 mg ml 71 bovine serum albumin, recombinant GST-PTP 1B, and the [ 32 P]RCM-L substrate (1000 d.p.m. pmol 71 ). The substrate was added last to initiate the reaction, which was then incubated at 308C for 10 min. The reaction was stopped by the addition of 10 ml of 100% trichloroacetic acid (w/v). The mixture was incubated on ice for 5 min and centrifuged 14 000 g for 5 min to pellet the protein from the mixture. An aliquot of 30 ml was removed from the supernatant for liquid scintillation counting to determine the amount of phosphate released from [
32 P]RCM-L.
Autophosphorylation of Src
To determine the time course of Src autophosphorylation, puri®ed Src protein was incubated at 308C with 0.2 mM ATP (10 000 d.p.m. pmol 71 ), 10 mM MgCl 2 in 75 mM EPPS-NaOH (pH 8.0), 5% glycerol, 0.005% Triton X-100 and 0.05% b-mercaptoethanol. At the indicated time, aliquots were removed and mixed with an equal volume of sample buer and prepared for SDS ± PAGE. Phosphorylated proteins were identi®ed by autoradiography after SDS ± PAGE. The phosphorylation level of Src was quanti®ed by liquid scintillation counting of the excised Src protein band. The stoichiometry of autophosphorylation was calculated by dividing the mole of phosphate incorporated by the mole of Src protein loaded onto the gel.
Dephosphorylation of Src by PTP 1B
Src was autophosphorylated by pre-incubating with [g-32 P]ATP-Mg as described above. The dephosphorylation of the autophosphorylated Src was performed by incubation with 10 U of PTP 1B in the presence of 10 mM Na 2 EDTA for the indicated time. The proteins were fractionated by SDS ± PAGE and the phosphorylation level of Src visualized by autoradiography and quanti®ed by liquid scintillation counting of the excised Src protein band. To determine the eect of PTP 1B treatment on the ability of Src to be inactivated by Csk phosphorylation, the Src sample treated as described above was assayed in the presence of excess Csk (Csk : Src=3 : 1 in molar ratio) and 1 mM ammonium molybdate to inhibit PTP 1B.
Inactivation of Src by Csk phosphorylation
To quantify the inactivation of Src by Csk, Src activity was assayed using RCM-L as substrate in the presence of excess Csk (Csk : Src=3 : 1 in molar ratio). Since RCM-L is a far superior substrate for Src than for Csk (dierence in V max /K m ratio4100-fold), Src activity can be accurately determined without removing Csk from the assay. The percentage of inactivation of Src by Csk is calculated as follows: (Src activity7Src activity in the presence of Csk)/ Src activity6100.
Cyanogen bromide digestion and peptide mapping of Src
After various treatments, Src was precipitated with 10% trichloroacetic acid and fractionated on SDS ± PAGE and the Src protein bands were excised. Cyanogen bromide digestion and peptide mapping were performed as described (Jove et al., 1989) .
Generation and expression of Yes Fa
The mutation of Tyr-426 to Phe-426 was introduced into the Yes coding sequence in the plasmid pGEX-Yes with PCR and other standard molecular biology methods (Sambrook et al., 1989) . The PCR ampli®ed portion was sequenced and the designed mutation was con®rmed. The resultant plasmid pGEX-Yes Fa was used to transform DH5a competent cells for protein expression. The mutant fusion protein, GST-Yes Fa , was expressed and puri®ed as previously described for the wild-type enzyme (Sun and Budde, 1997b) .
Abbreviations GST, glutathione S-transferase; PTK, protein tyrosine kinase; RCM-L, carboxymethylated-maleylated, reduced lysozyme; PTP, protein tyrosine phosphatase; SH domain, Src homology domain.
